Role of the Nasal Environment in Obesity
NCT06153654 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2023-12-01
Summary
The primary aim of this study is to investigate the nasal environment in obese and lean individuals.
Conditions
- Adiposity
Sponsors & Collaborators
-
Katharina Timper
lead OTHER
Principal Investigators
-
Katharina Timper, Prof. Dr. med. · University Hospital, Basel, Switzerland
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-07-30
- Primary Completion
- 2025-07-31
- Completion
- 2025-09-30
Countries
- Switzerland
Study Locations
More Related Trials
-
The Nasal Microbiome and Its Importance in Disease
NCT05061329 ·Status: RECRUITING
-
Etokimab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
NCT03614923 ·Status: COMPLETED ·Phase: PHASE2
-
Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction
NCT05445921 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
CST1-Guided Oral Glucocorticoids Management for CRSwNP
NCT05598411 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Distribution of Topical Nasal Medication Within the Nasal Cavity and Sinuses by Radiographic Comparison
NCT00626366 ·Status: COMPLETED ·Phase: NA
-
Use of Immunosuppressive Therapy for Sarcoidosis
NCT02356445 ·Status: UNKNOWN
-
Study of the Pathogenesis of Olfactory Disorders in COVID-19
NCT04366934 ·Status: COMPLETED
-
A Study of Nasal Glucagon in Participants With a Common Cold
NCT02778100 ·Status: COMPLETED ·Phase: PHASE1
-
NO Measurements in Screening for Asthma and OSA, in Patients With CRSwNP
NCT03963648 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Olfactive Training on Loss of Smell and Taste Caused by SARS CoV2 COVID-19 (Covid-Smell)
NCT07190911 ·Status: COMPLETED ·Phase: NA
-
Administration of Systemic Corticosteroids and the Recovery of Gustatory Functions in Patients With COVID-19
NCT05148832 ·Status: COMPLETED ·Phase: NA
-
An Observational Study to Evaluate The Relationship of Nasal Mucus Properties and Symptoms
NCT01553110 ·Status: COMPLETED
-
Sino-nasal Inhalation of Colistin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Colonization
NCT01035853 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of CM326 in Patients With Chronic Rhinosinusitis With Nasal Polyps
NCT05324137 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
SA55 Novel Coronavirus Broad-spectrum Neutralizing Antibody Nasal Spray in Health People
NCT06048393 ·Status: UNKNOWN ·Phase: PHASE1
-
Value of Platelet-Rich Plasma in Post Severe Acute Respiratory Syndrome Coronavirus 2
NCT05395845 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
The Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyps
NCT05131464 ·Status: COMPLETED ·Phase: PHASE2
-
Factors Influencing the Prognosis of Olfactory Dysfunction After Upper Sensation
NCT04918953 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Prevalence of ENT Diseseas
NCT06105346 ·Status: NOT_YET_RECRUITING
-
A Randomized Double Dummy Double Blind Dose Determining Place-bo Controlled Study to Evaluate Efficacy of Investigational Product E-RH-06 at 2 Dose Levels for the Metabolic Management of Chronic or Recurrent, Non-infective Nasal Congestion With-or-without Rhinorrhea.
NCT01546662 ·Status: UNKNOWN ·Phase: NA
-
Pilot Study To Evaluate A Pharmacologically Active Nasal Sponge Following Endoscopic Sinus Surgery
NCT00705354 ·Status: WITHDRAWN ·Phase: NA
-
Evolution of the Endonasal Microbiota in Patients With Chronic Rhinosinusitis
NCT04418622 ·Status: COMPLETED
-
Study of Mitomycin C and Nasal Splint to Treat Nasal Synechiae
NCT00966056 ·Status: COMPLETED ·Phase: PHASE2
-
Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation
NCT06482138 ·Status: RECRUITING ·Phase: NA
-
Investigate the Role of microRNA in Chronic Rhinosinusitis From DC-Th Axis
NCT02325596 ·Status: UNKNOWN